XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial | |
Song, Yuanlin; Yao, Chen; Yao, Yongming; Han, Hui; Zhao, Xiaodong; Yu, Kaijiang; Liu, Luyi; Xu, Ying; Liu, Zhongmin; Zhou, Qingshan | |
刊名 | CRITICAL CARE MEDICINE |
2019 | |
卷号 | 47期号:9页码:e735-e743 |
关键词 | 28-day mortality rate pneumonia severity index randomized controlled trial severe community-acquired pneumonia XueBiJing injection |
DOI | 10.1097/CCM.0000000000003842 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4550651 |
专题 | 山东大学 |
作者单位 | 1.Fudan Univ, Zhongshan Hosp, Dept Resp Med, Shanghai, Peoples R China. 2.Peking Univ, Hosp 1, Dept Med Stat, |
推荐引用方式 GB/T 7714 | Song, Yuanlin,Yao, Chen,Yao, Yongming,et al. XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial[J]. CRITICAL CARE MEDICINE,2019,47(9):e735-e743. |
APA | Song, Yuanlin.,Yao, Chen.,Yao, Yongming.,Han, Hui.,Zhao, Xiaodong.,...&Geng D.(2019).XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial.CRITICAL CARE MEDICINE,47(9),e735-e743. |
MLA | Song, Yuanlin,et al."XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial".CRITICAL CARE MEDICINE 47.9(2019):e735-e743. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论